S&P 500 Futures
(-0.07%) 5 304.50 points
Dow J Futures
(-0.02%) 40 134 points
Nasdaq Futures
(-0.11%) 18 484 points
Oil
(0.77%) $81.98
Gas
(-1.75%) $1.688
Gold
(0.28%) $2 218.80
Silver
(-0.64%) $24.59
Platinum
(-0.01%) $909.60
USD/EUR
(0.46%) $0.928
USD/NOK
(0.69%) $10.84
USD/GBP
(0.28%) $0.793
USD/RUB
(-0.15%) $92.31

Realtime updates for Collegium Pharmaceutical [COLL]

Exchange: NASDAQ Sector: Healthcare Industry: Drug Manufacturersā€”Specialty & Generic
Last Updated27 Mar 2024 @ 16:00

2.45% $ 40.91

SELL 61662 min ago

@ $32.43

Issued: 14 Feb 2024 @ 09:32


Return: 26.15%


Previous signal: Feb 13 - 09:30


Previous signal: Buy


Return: -1.90 %

Live Chart Being Loaded With Signals

Commentary (27 Mar 2024 @ 16:00):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302
Profile picture for Collegium Pharmaceutical Inc

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ER for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment...

Stats
Today's Volume 349 937
Average Volume 450 803
Market Cap 1.31B
EPS $0 ( 2024-02-22 )
Next earnings date ( $1.500 ) 2024-05-02
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E 31.71
ATR14 $0.0280 (0.07%)
Insider Trading
Date Person Action Amount type
2024-02-29 Smith Thomas B Sell 995 Common Stock
2024-02-26 Dreyer Scott Sell 9 336 Common Stock
2024-02-26 Dreyer Scott Sell 664 Common Stock
2024-02-12 Tupper Colleen Buy 30 856 Common Stock
2024-02-12 Tupper Colleen Sell 16 868 Common Stock
INSIDER POWER
14.73
Last 100 transactions
Buy: 1 331 449 | Sell: 1 023 987

Volume Correlation

Long: 0.33 (neutral)
Short: 0.61 (weak)
Signal:(74.352) Neutral

Collegium Pharmaceutical Correlation

10 Most Positive Correlations
BNIXU0.971
AHCO0.934
MDRX0.929
CARA0.928
RKDA0.927
ATRA0.925
CSSE0.925
DISH0.924
ETSY0.923
UPLD0.922
10 Most Negative Correlations
MSDA-0.922
MTEK-0.914
BRIVU-0.911
VLAT-0.91
TIOAU-0.909
ADAL-0.908
PPYAU-0.906
NVCN-0.902
BNIX-0.902
BRIV-0.899

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Collegium Pharmaceutical Correlation - Currency/Commodity

The country flag 0.45
( neutral )
The country flag 0.30
( neutral )
The country flag 0.00
( neutral )
The country flag 0.19
( neutral )
The country flag -0.11
( neutral )
The country flag 0.15
( neutral )

Collegium Pharmaceutical Financials

Annual 2023
Revenue: $566.77M
Gross Profit: $326.17M (57.55 %)
EPS: $1.430
Q4 2023
Revenue: $149.75M
Gross Profit: $94.63M (63.19 %)
EPS: $0.950
Q3 2023
Revenue: $136.71M
Gross Profit: $80.31M (58.75 %)
EPS: $0.610
Q2 2023
Revenue: $135.55M
Gross Profit: $73.83M (54.47 %)
EPS: $0.380

Financial Reports:

No articles found.

Collegium Pharmaceutical

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ER for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Stoughton, Massachusetts.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators